These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26895435)

  • 1. [Localized prostate cancer: Radiotherapeutic concepts].
    Grimm M; Wenz F
    Urologe A; 2016 Mar; 55(3):326-32. PubMed ID: 26895435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Curative radiotherapy of localized prostate cancer. Treatment methods and results].
    Schwarz R
    Urologe A; 2003 Sep; 42(9):1212-20. PubMed ID: 14504754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate.
    Myers MA; Hagan MP; Todor D; Gilbert L; Mukhopadhyay N; Randolf J; Heimiller J; Anscher MS
    Brachytherapy; 2012; 11(4):292-8. PubMed ID: 22464911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy.
    Khoo VS
    Clin Oncol (R Coll Radiol); 2005 Oct; 17(7):560-71. PubMed ID: 16238144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report.
    Valero J; Cambeiro M; Galán C; Teijeira M; Romero P; Zudaire J; Moreno M; Ciérvide R; Aristu JJ; Martínez-Monge R
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):386-92. PubMed ID: 19427741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
    Teh BS; Paulino A; Butler EB
    Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the best way to radiate the prostate in 2016?
    Moon DH; Efstathiou JA; Chen RC
    Urol Oncol; 2017 Feb; 35(2):59-68. PubMed ID: 27395453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.
    Al-Salihi O; Mitra A; Payne H
    Prostate Cancer Prostatic Dis; 2006; 9(4):370-3. PubMed ID: 16832383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-confined prostate carcinoma radiation brachytherapy compared with external either photon- or hadron-beam radiation therapy. Just a short up-to-date.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):769-74. PubMed ID: 21780545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer.
    Hurwitz MD
    Nat Clin Pract Oncol; 2008 Nov; 5(11):668-76. PubMed ID: 18825143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: a comparison of Australian series.
    Wilcox SW; Aherne NJ; McLachlan CS; McKay MJ; Last AJ; Shakespeare TP
    J Med Imaging Radiat Oncol; 2015 Feb; 59(1):125-33. PubMed ID: 25588566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localized intermediate- to high-risk prostate cancer].
    Tritschler S; Ganswindt U; Stief CG
    Urologe A; 2016 Mar; 55(3):318-25. PubMed ID: 26873385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technological advances in radiotherapy for the treatment of localised prostate cancer.
    Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
    Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
    Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity of conformal high dose interstitial brachytherapy boost in prostate cancer.
    Soumarová R; Homola L; Stursa M; Perková H
    Neoplasma; 2006; 53(5):410-7. PubMed ID: 17013535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.